Updated International Society of Geriatric Oncology COVID-19 Working Group Recommendations on COVID-19 Vaccination Among Older Adults with Cancer

Overview

Journal J Geriatr Oncol

Publisher Elsevier

Specialty Geriatrics

Date 2022 Jul 19

PMID 35853816

Authors

Enrique Soto-Perez-de-Celis

Anna Rachelle Mislang

Celia Gabriela Hernandez-Favela

Chiara Russo

Giuseppe Colloca

Grant R Williams

Shane OHanlon

Lisa Cooper

Anita ODonovan

Riccardo A Audisio

Kwok-Leung Cheung

Regina Girones-Sarrio

Reinhard Stauder

Michael Jaklitsch

Clarito Cairo

Luiz Antonio Gil Jr

Mahmood Alam

Schroder Sattar

Kumud Kantilal

Kah Poh Loh

Stuart M Lichtman

Etienne Brain

Hans Wildiers

Ravindran Kanesvaran

Nicolo Matteo Luca Battisti

Affiliations

Soon will be listed here.

Citing Articles

The presence of senescent peripheral T-cells is negatively correlated to COVID-19 vaccine-induced immunity in cancer patients under 70 years of age.

Orillard E, Spehner L, Mansi L, Bouard A, Falcoz A, Lepiller Q Front Immunol. 2023; 14:1160664.

PMID: 37334387 PMC: 10272422. DOI: 10.3389/fimmu.2023.1160664.

References

Collier D, Ferreira I, Kotagiri P, Datir R, Lim E, Touizer E . Age-related immune response heterogeneity to SARS-CoV-2 vaccine BNT162b2. Nature. 2021; 596(7872):417-422. PMC: 8373615. DOI: 10.1038/s41586-021-03739-1. View

Moore J, Ricaldi J, Rose C, Fuld J, Parise M, Kang G . Disparities in Incidence of COVID-19 Among Underrepresented Racial/Ethnic Groups in Counties Identified as Hotspots During June 5-18, 2020 - 22 States, February-June 2020. MMWR Morb Mortal Wkly Rep. 2020; 69(33):1122-1126. PMC: 7439982. DOI: 10.15585/mmwr.mm6933e1. View

Bar-On Y, Goldberg Y, Mandel M, Bodenheimer O, Amir O, Freedman L . Protection by a Fourth Dose of BNT162b2 against Omicron in Israel. N Engl J Med. 2022; 386(18):1712-1720. PMC: 9006780. DOI: 10.1056/NEJMoa2201570. View

Brockman M, Mwimanzi F, Lapointe H, Sang Y, Agafitei O, Cheung P . Reduced Magnitude and Durability of Humoral Immune Responses to COVID-19 mRNA Vaccines Among Older Adults. J Infect Dis. 2021; 225(7):1129-1140. PMC: 8689804. DOI: 10.1093/infdis/jiab592. View

Vanshylla K, Tober-Lau P, Gruell H, Munn F, Eggeling R, Pfeifer N . Durability of omicron-neutralising serum activity after mRNA booster immunisation in older adults. Lancet Infect Dis. 2022; 22(4):445-446. PMC: 8884748. DOI: 10.1016/S1473-3099(22)00135-9. View

Elkrief A, Hennessy C, Kuderer N, Rubinstein S, Wulff-Burchfield E, Rosovsky R . Geriatric risk factors for serious COVID-19 outcomes among older adults with cancer: a cohort study from the COVID-19 and Cancer Consortium. Lancet Healthy Longev. 2022; 3(3):e143-e152. PMC: 8843069. DOI: 10.1016/S2666-7568(22)00009-5. View

Mbaeyi S, Oliver S, Collins J, Godfrey M, Goswami N, Hadler S . The Advisory Committee on Immunization Practices' Interim Recommendations for Additional Primary and Booster Doses of COVID-19 Vaccines - United States, 2021. MMWR Morb Mortal Wkly Rep. 2021; 70(44):1545-1552. PMC: 8568093. DOI: 10.15585/mmwr.mm7044e2. View

Naranbhai V, Denis K, Lam E, Ofoman O, Garcia-Beltran W, Mairena C . Neutralization breadth of SARS-CoV-2 viral variants following primary series and booster SARS-CoV-2 vaccines in patients with cancer. Cancer Cell. 2022; 40(1):103-108.e2. PMC: 8730528. DOI: 10.1016/j.ccell.2021.12.002. View

Bag Soytas R, Cengiz M, Islamoglu M, Uysal B, Yavuzer S, Yavuzer H . Antibody responses to COVID-19 vaccines in older adults. J Med Virol. 2021; 94(4):1650-1654. DOI: 10.1002/jmv.27531. View

10.

Helfand B, Webb M, Gartaganis S, Fuller L, Kwon C, Inouye S . The Exclusion of Older Persons From Vaccine and Treatment Trials for Coronavirus Disease 2019-Missing the Target. JAMA Intern Med. 2020; 180(11):1546-1549. PMC: 7522773. DOI: 10.1001/jamainternmed.2020.5084. View

11.

Thu T, Ngoc P, Hai N, Tuan L . Effect of the social distancing measures on the spread of COVID-19 in 10 highly infected countries. Sci Total Environ. 2020; 742:140430. PMC: 7307990. DOI: 10.1016/j.scitotenv.2020.140430. View

12.

Pinato D, Aguilar-Company J, Ferrante D, Hanbury G, Bower M, Salazar R . Outcomes of the SARS-CoV-2 omicron (B.1.1.529) variant outbreak among vaccinated and unvaccinated patients with cancer in Europe: results from the retrospective, multicentre, OnCovid registry study. Lancet Oncol. 2022; 23(7):865-875. PMC: 9162476. DOI: 10.1016/S1470-2045(22)00273-X. View

13.

Crooke S, Ovsyannikova I, Poland G, Kennedy R . Immunosenescence and human vaccine immune responses. Immun Ageing. 2019; 16:25. PMC: 6743147. DOI: 10.1186/s12979-019-0164-9. View

14.

Araf Y, Akter F, Tang Y, Fatemi R, Parvez M, Zheng C . Omicron variant of SARS-CoV-2: Genomics, transmissibility, and responses to current COVID-19 vaccines. J Med Virol. 2022; 94(5):1825-1832. PMC: 9015557. DOI: 10.1002/jmv.27588. View

15.

Kuderer N, Choueiri T, Shah D, Shyr Y, Rubinstein S, Rivera D . Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study. Lancet. 2020; 395(10241):1907-1918. PMC: 7255743. DOI: 10.1016/S0140-6736(20)31187-9. View

16.

Fendler A, Shepherd S, Au L, Wilkinson K, Wu M, Byrne F . Adaptive immunity and neutralizing antibodies against SARS-CoV-2 variants of concern following vaccination in patients with cancer: the CAPTURE study. Nat Cancer. 2022; 2(12):1305-1320. DOI: 10.1038/s43018-021-00274-w. View

17.

Embi P, Levy M, Naleway A, Patel P, Gaglani M, Natarajan K . Effectiveness of 2-Dose Vaccination with mRNA COVID-19 Vaccines Against COVID-19-Associated Hospitalizations Among Immunocompromised Adults - Nine States, January-September 2021. MMWR Morb Mortal Wkly Rep. 2021; 70(44):1553-1559. PMC: 8568092. DOI: 10.15585/mmwr.mm7044e3. View

18.

Song Q, Bates B, Shao Y, Hsu F, Liu F, Madhira V . Risk and Outcome of Breakthrough COVID-19 Infections in Vaccinated Patients With Cancer: Real-World Evidence From the National COVID Cohort Collaborative. J Clin Oncol. 2022; 40(13):1414-1427. PMC: 9061155. DOI: 10.1200/JCO.21.02419. View

19.

Shakeel C, Mujeeb A, Mirza M, Chaudhry B, Khan S . Global COVID-19 Vaccine Acceptance: A Systematic Review of Associated Social and Behavioral Factors. Vaccines (Basel). 2022; 10(1). PMC: 8779795. DOI: 10.3390/vaccines10010110. View

20.

Battisti N, Mislang A, Cooper L, ODonovan A, Audisio R, Cheung K . Adapting care for older cancer patients during the COVID-19 pandemic: Recommendations from the International Society of Geriatric Oncology (SIOG) COVID-19 Working Group. J Geriatr Oncol. 2020; 11(8):1190-1198. PMC: 7365054. DOI: 10.1016/j.jgo.2020.07.008. View